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The amino acid sequence of a heat-stable enterotoxin produced by a human strain of enterotoxinogenic 
Escherichia coli was determined to be (disregarding the sulfide bridges): 
Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr 
Compensated amino acid exchanges have occurred in positions 11 and 18 in relation to the structure of 
a heat-stable enterotoxin from a different human strain of Escherichia coli 
Heat-stable enterotoxin Escherichia coli, pathogenic for man 
Compensated amino acid exchange 
Amino acid sequence 
1. INTRODUCTION 
Enterotoxinogenic Escherichia coli is a common 
cause of diarrhoea in man and animals [l]. Two 
types of enterotoxin are produced, either alone or 
in combination [l]. One is a heat-labile, large 
enterotoxin composed of one 25500-M, subunit 
and four or five 11000-M, subunits [2]. Its 
mechanism of action appears to be similar to that 
of cholera toxin since it exerts its effects by 
stimulating the adenylate cyclase within the epi- 
thelial cells of the small intestine [3]. The other 
type of enterotoxin is a heat-stable, smaller poly- 
peptide of about 2000-5000 M, [4-61 and its 
mechanism of action may involve the guanylate 
cyclase system [7]. Host susceptibility, as well as 
molecular mass, amino acid composition and 
methanol solubility vary for heat-stable nterotox- 
ins from different strains [4-6,8]. 
The primary structure of a purified heat-stable 
enterotoxin (ST) produced by E. coli pathogenic 
for man, has now been determined. The amino 
acid sequence of this human enterotoxin is in full 
agreement with that deduced from a nucleotide se- 
quence for a porcine heat-stable enterotoxin [9]. 
However, in relation to another human enterotox- 
in [lo], two amino acid exchanges have occurred. 
Structurally, these constitute compensated ex- 
changes, which together with additional variations 
allow further conclusions on the relative impor- 
tance of different positions of the toxin. 
2. MATERIALS AND METHODS 
The heat-stable nterotoxin produced by human 
strain C57/26C2 of E. coli, was purified by steps 
of hydrophobic interaction chromatography, ex- 
clusion chromatography, and ion-exchange chro- 
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matography, as in [ll], yielding the expected 
amino acid composition, potency, and biological 
activity. 
Toxin (210 pg) was dissolved in 1.4 ml 0.4 M 
Tris-HCl (pH 8.15) containing 2 mM EDTA and 
6 M guanidine-HCl. The solution was kept under 
nitrogen, and 25 ~1 0.5 M dithiothreitol was add- 
ed. After reduction for 2 h at 37”C, iodo[14C]ace- 
tate (35 &i) was added. The carboxymethylation 
was carried out for 2 h in the dark at room 
temperature under nitrogen, after which the reac- 
tion was stopped by 100~1 2-mercaptoethanol. 
After another 10 min at 37”C, the product was 
dialyzed against 30% acetic acid in Spectrapor 6 
dialysis tubing (Mr cut off: 1000). 
The amino acid composition was determined 
with a Beckman 121 M analyzer after hydrolysis at 
110°C for 24 h in evacuated tubes containing 6 M 
HCI with 0.5% phenol. 
Sequence degradations of about 50 nmol car- 
boxymethylated toxin were carried out in a 
Beckman 890 D liquid-phase sequencer, using a 
0.1 M Quadrol peptide program in the presence of 
Polybrene, added together with 200 nmol glycine 
and pre-cycled [ 121. Phenylthiohydantoin deriva- 
tives were identified by high-pressure liquid chro- 
matography in a Hewlett-Packard 1084 B instru- 
ment on a Nucleosil C~S column using an 
acetate/acetonitrile gradient [ 131 supplemented 
where possible by thin-layer chromatography [141, 
and for carboxymethylcysteine by radioactivity 
measurements. 
3. RESULTS 
The heat-stable enterotoxin was [‘4C]carboxy- 
methylated and submitted to degradations in a 
liquid-phase sequencer. The structure obtained is 
given in fig.1. Residues were identified up to and 
including the C-terminus in position 18. The com- 
position from this structure is identical to the 
analytical composition from acid hydrolysis of the 
toxin [ 111, showing that the structure is complete 
and consistent with all data. 
The C-terminal amino acid of the enterotoxin is 
tyrosine. Asparagine is identified as the N-terminal 
residue, and also in position 11. The 6 cysteine 
derivatives are found at positions 5, 6, 9, 10, 14 
and 17, and no basic amino acids are present in the 
toxin. 
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Fig. 1. Results of sequence analysis of heat-stable 
enterotoxin produced by Escherichia coii, strain 
C57/26C2, pathogenic for man: ( -) residues 
identified by sequencer degradations; (H) identification 
by high performance liquid chromatography (with 
values in nmol stable residues recovered from 
application of 50 nmol toxin); (T) by thin-layer chroma- 
tography; (R) by 14C measurements. 
4. DISCUSSION 
The amino acid sequence of carboxymethylated 
heat-stable enterotoxin from the human strain 
C57/26C2 has been determined. It consists of 18 
residues and is in full agreement with the amino 
acid composition; 6 of the positions are occupied 
by the cysteine derivatives. Treatment of the native 
peptide with reducing agents such as dithiothreitol, 
destroys the biological activity, which suggests the 
presence of disulfide linkages in the intact 
molecule. Such a compact structure with 3 
disulfide bridges in 18 residues, probably accounts 
for the pH and heat stability, as well as for the 
hydrophobic properties of the toxin [I 11. 
Previous reports show the existence of heat- 
stable enterotoxins of Mr 2000-10000 [4-6,151, 
which suggests that the ST molecule is synthesized 
as a precursor, and that it, in common with many 
exported proteins, is subject to specific proteolytic 
processing associated with transmembrane 
transport. The report [9] of a porcine ST, for 
which the amino acid sequence was deduced from 
the nucleotide sequence, agrees with our report. 
The last 18 amino acid residues prior to the stop 
codon are identical to the present sequence. 
However, the sequence of a human ST isolated 
from another strain [lo], differs from our struc- 
ture in positions 11 and 18. We find asparagine in 
position 11 and tyrosine in position 18, while the 
other sequence has tyrosine in position 11 and 
asparagine in position 18. Consequently, the dif- 
ferences in positions 11 and 18 are not unique to 
human and porcine strains but a property of the 
toxin not related to the host origin. Two further se- 
quences of heat-stable enterotoxins produced by 
different human strains have been established, one 
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Fig.2. Comparison of structures of heat-stable enterotoxins produced by Escherichia coli: (a) present structure; (b) 
human ST from [lo]; (c) porcine ST deduced from a nucleotide sequence [9]; (d) human ST deduced from a nucleotide 
sequence [16]; (e) human ST from [17]; hitherto invariable residues are boxed. 
directly determined and the other deduced from 
the nucleotide sequence [16,17]. Both these toxins 
contain 19 amino acid residues, by having an extra 
N-terminal residue in relation to the present se- 
quence. The structures are compared in fig.2. 
Interestingly, the 18-residue human ST that dif- 
fers in positions 11 and 18 from our sequence, ex- 
hibits differences suggesting the presence of com- 
pensated amino acid exchanges. Apparently, 
asparagine and tyrosine can complement each 
other at these positions in the two toxins. Taking 
all toxins into account, they also exhibit single dif- 
ferences in these positions, again of a compensated 
nature. 
Positions 11 and 18 may therefore be ascribed a 
certain function. They can apparently accept some 
exchanges, in contrast to most cysteine-adjacent 
positions (which are hitherto invariable) and a few 
other positions also containing single exchanges. 
Independent of the functional correlation, the pre- 
sent results show a new structure for human ST, 
and indicate two interesting positions, 11 and 18, 
which may have compensated functions in the ac- 
tive enterotoxin. 
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